AUTL
Autolus Therapeutics plc
1.90$
+4.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +50.9% | +334.9% | +46.4% | +0.0% | +39.5% | -3.1% | +37.8% | +20.9% | -23.4% | +108.5% | -24.7% | |
| – | +169.1% | +360.7% | +39.8% | +0.0% | +25.2% | -22.2% | +78.9% | +22.7% | -35.3% | +140.1% | -34.0% | |
| – | +175.5% | +388.5% | +38.1% | +0.0% | +11.7% | -27.1% | +101.4% | +23.2% | -37.4% | -5.1% | -54.2% | |
| – | +175.5% | +388.5% | +38.1% | +0.0% | +11.7% | -27.1% | +101.4% | +23.2% | -37.4% | +145.5% | -48.9% | |
| – | +191.8% | +117.1% | +43.9% | +36.1% | +229.5% | -2.7% | -99.8% | +42,511.8% | -96.4% | +4,507.4% | +57.1% | |
| – | – | – | – | +0.0% | +253.7% | -480.1% | – | +39.8% | -266.0% | – | +702.5% | |
| – | +437.6% | +89.9% | +118.9% | +47.6% | +158.3% | +73.9% | -41.7% | +11.7% | – | – | – | |
| – | -7.3% | -23.2% | +27.4% | +0.0% | -97.3% | -37.8% | -58.9% | – | – | – | +60.1% | |
| – | +79.3% | +73.5% | +106.5% | +0.0% | +289.0% | +72.9% | +9.5% | +107.7% | +37.7% | +34.7% | +15.6% | |
| – | +40.4% | +84.0% | +148.7% | +0.0% | +99.6% | +34.6% | -15.1% | +62.4% | -3.5% | +35.8% | +20.9% | |
| – | – | – | – | – | – | +43.0% | +24.0% | +13.1% | +0.3% | -40.7% | +385.8% | |
| – | -14.9% | +35.3% | +543.2% | -75.7% | -64.6% | +110.5% | -81.0% | +23.2% | -80.6% | +1,811.7% | +56.6% | |
| – | +48.2% | +364.7% | +43.9% | +0.0% | +24.2% | -17.6% | +49.2% | -4.7% | -62.7% | +283.3% | -58.3% | |
| – | – | – | – | +0.0% | -244.7% | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +129.0% | +0.0% | +36.5% | +19.7% | +39.8% | +31.8% | +83.1% | +46.7% | +4.3% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.